Journals / Journal of Medicine and Palliative Care / 2026 / Volume: 7 Issue: 5

Placental NLRP3 expression across placenta accreta spectrum, placenta previa, and other non-PAS placental pathologies: an immunohistochemical study

Dinçer Sümer(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Perinatoloji Kliniği)0000-0002-7034-6811
Hitay Cemre Metindoğan(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Tıbbi Patoloji Kliniği)0009-0005-3149-2006
Firdevs Şahin Duran(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Tıbbi Patoloji Kliniği)0000-0001-9244-9590
Ahmet Arif Filiz(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Perinatoloji Kliniği)0000-0002-6137-0270
Özgür Volkan Akbulut(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Perinatoloji Kliniği)0000-0002-1960-2146
Büşra Seçilir(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Kadın Hastalıkları ve Doğum Anabilim Dalı)0009-0002-2140-7152
Furkan Akın(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Kadın Hastalıkları ve Doğum Anabilim Dalı)0009-0004-4026-1974
Zehra Yılmaz(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Perinatoloji Kliniği)0000-0002-8719-1879
Şevki Çelen(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Perinatoloji Kliniği)0000-0001-7033-3474
Ali Çağlar(Sağlık Bilimleri Üniversitesi Etlik Şehir Hastanesi Perinatoloji Kliniği)0000-0002-7022-3029
Pages
—
Publication Date
2026-10-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although NLRP3 may be involved in inflammatory pathways related to abnormal placentation, its diagnostic performance was modest and its independent predictive value appeared limited after adjustment for established clinical risk factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Placenta accreta spectrum (PAS) is characterized by abnormal trophoblast invasion and is associated with substantial maternal morbidity.
📊
Key Findings & Data:This study aimed to evaluate placental NLRP3 protein expression across PAS, placenta previa, and other non-PAS placental pathologies.
💡
Conclusion & Impact:Although NLRP3 may be involved in inflammatory pathways related to abnormal placentation, its diagnostic performance was modest and its independent predictive value appeared limited after adjustment for established clinical risk factors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Placenta accreta spectrum · NLR family · pyrin domain-containing 3 protein

Abstract

Aims: Placenta accreta spectrum (PAS) is characterized by abnormal trophoblast invasion and is associated with substantial maternal morbidity. This study aimed to evaluate placental NLRP3 protein expression across PAS, placenta previa, and other non-PAS placental pathologies. Methods: This retrospective study included 52 placental specimens: 26 PAS cases, 11 placenta previa cases, and 15 other non-PAS placental pathologies. NLRP3 expression was assessed immunohistochemically using a semi-quantitative scoring system. Logistic regression and receiver operating characteristic (ROC) analyses were performed to evaluate the association of NLRP3 with PAS. Results: NLRP3 staining scores differed significantly across the three study groups (p=0.036). However, none of the pairwise comparisons remained statistically significant after Bonferroni correction, although PAS showed a trend toward higher NLRP3 expression than other non-PAS placental pathologies before correction (uncorrected p=0.018), these findings should be considered exploratory. In univariable logistic regression, higher NLRP3 expression was associated with PAS (OR 1.318, 95% CI 1.041–1.669, p=0.022). After adjustment, the number of previous cesarean deliveries remained independently associated with PAS (aOR 8.621, 95% CI 2.325–31.959, p=0.001), whereas NLRP3 expression showed a borderline independent association (aOR 1.480, 95% CI 0.988–2.216, p=0.057). ROC analysis demonstrated modest discriminative performance in this cohort (AUC 0.685, 95% CI 0.540–0.830, p=0.022). Conclusion: Placental NLRP3 expression showed a trend toward higher expression in PAS but pairwise differences did not remain statistically significant after Bonferroni correction. Accordingly, these findings should be considered exploratory and hypothesis-generating. Although NLRP3 may be involved in inflammatory pathways related to abnormal placentation, its diagnostic performance was modest and its independent predictive value appeared limited after adjustment for established clinical risk factors.

🔖

Cite This Article

Sümer, D., Metindoğan, H. C., Duran, F. Ş., Filiz, A. A., Akbulut, Ö. V., Seçilir, B., Akın, F., Yılmaz, Z., Çelen, Ş., Çağlar, A. (2026). Placental NLRP3 expression across placenta accreta spectrum, placenta previa, and other non-PAS placental pathologies: an immunohistochemical study. Journal of Medicine and Palliative Care, Volume: 7 Issue: 5. https://ajindex.com/articles/1668091

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20-24. doi:10.1002/ijgo.12761
  2. Afshar Y, Kashani Ligumsky L, Bartels HC, et al. Biology and pathophysiology of placenta accreta spectrum disorder. Obstet Gynecol. 2025;145(3):611-620. doi:10.1097/AOG.0000000000005903
  3. Park S, Shin J, Bae J, et al. SIRT1 alleviates LPS-induced IL-1β production by suppressing NLRP3 inflammasome activation and ROS production in trophoblasts. Cells. 2020;9(3):728. doi:10.3390/cells9030728
  4. Artemyeva KA, Kulikov IA, Nizyaeva NV, et al. Serum markers of abnormal placental attachment in pregnant women. Bull Exp Biol Med. 2025;178(6):681-684. doi:10.1007/s10517-025-06397-9
  5. Ortega MA, De Leon-Oliva D, García-Montero C, et al. Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities. Front Immunol. 2023;14:1232629. doi:10.3389/fimmu.2023.1232629
  6. Deliloğlu B, Tüzün F, Aysal A, et al. Relationship between placental autophagy and inflammasome activities with morbidity of extremely preterm infants. Turk J Pediatr. 2022;64(6):1001-1012. doi:10.24953/turkjped.2021.5341
  7. Garcia-Puente LM, Fraile-Martinez O, García-Montero C, et al. Placentas from women with late-onset preeclampsia exhibit increased expression of the NLRP3 inflammasome machinery. Biomolecules. 2023;13(11):1644. doi:10.3390/biom13111644
  8. Stødle GS, Silva GB, Tangerås LH, et al. Placental inflammation in pre-eclampsia by NOD-like receptor protein 3 inflammasome activation in trophoblasts. Clin Exp Immunol. 2018;193(1):84-94. doi:10.1111/cei.13130
  9. Jauniaux E, Alfirevic Z, Bhide AG, et al. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG. 2019;126(1):e1-e48. doi:10.1111/1471-0528.15306
  10. Peiró G, Diebold J, Baretton GB, et al. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome. Int J Gynecol Pathol. 2001;20(4): 359-367. doi:10.1097/00004347-200110000-00008
  11. Brustmann H. Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study. Gynecol Oncol. 2004;92(1):268-276. doi:10.1016/j.ygyno.2003.10.029
  12. Hughes MM, O’Neill LAJ. Metabolic regulation of NLRP3. Immunol Rev. 2018;281(1):88-98. doi:10.1111/imr.12608
  13. Olona A, Leishman S, Anand PK. The NLRP3 inflammasome: regulation by metabolic signals. Trends Immunol. 2022;43(12):978-989. doi:10.1016/j.it.2022.10.003
  14. Moss CG, Dilworth MR, Harris LK, et al. Understanding a potential role for the NLRP3 inflammasome in placenta-mediated pregnancy complications. Am J Reprod Immunol. 2025;93(4):e70077. doi:10.1111/aji.70077